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Abstract 
Much attention has recently been focussed on the lysosome as a signalling hub. Following the initial 
discovery that localisation of the nutrient sensitive kinase, mTORC1, to the lysosome was essential 
for mTORC1 activation, the field has rapidly expanded to reveal the role of the lysosome as a 
platform permitting the coordination of several homeostatic signalling pathways. Much is now 
understood about how the lysosome contributes to amino acid sensing by mTORC1, the involvement 
of the energy sensing kinase, AMPK, at the lysosome and how both AMPK and mTORC1 feedback to 
lysosomal biogenesis and regeneration following autophagy. This review will cover the classical role 
of the lysosome in autophagy, the dynamic signalling interactions which take place on the lysosomal 
surface and the multiple levels of cross-talk which exist between lysosomes, AMPK and mTORC1. 
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1. What is the lysosome? 
The lysosome was first identified from tissue fractionation studies which aimed to analyse the 
intracellular distribution of rat liver enzymes [1]. Following the realisation that five acid hydrolase 
enzymes all were present in the same membrane-limited structure, it was proposed that these 
organelles were involved in intracellular digestion and hence termed lysosomes (Greek for ͚digestiǀe 
ďodǇ͛Ϳ [2]. 
Lysosomes are classically associated with the process of autophagy. Macroautophagy (hereafter 
referred to as autophagy) is a highly conserved process used to clear long-lived proteins and 
orgaŶelles froŵ the Đell, iŶ ǁhiĐh the lǇsosoŵe forŵs the ultiŵate ͚aĐĐeptor͛ of the ŵaterial to ďe 
degraded (reviewed in [3]). Cargo can also be delivered to lysosomes from the endocytic pathway 
and phagocytosis. Upon reaching the lysosome, the acid hydrolases it contains function to degrade 
the cargo. This releases breakdown products which can be recycled into new biomolecules. The 
lysosome itself must also be reformed, through the maturation of endolysosomes or 
reformation/budding from autolysosomes [4,5]. 
Lysosome biosynthesis requires the coordinated transcription of many genes encoding lysosomal 
proteins. These genes have a common palindromic motif, called the Coordinated Lysosomal 
Expression and Regulation (CLEAR) element, which is a target of transcription factor EB (TFEB) [6].  
More than 100 proteins are contained in the lysosome membrane, including the vacuolar H+-ATPase 
(v-ATPase). This is a multimeric protein pump which is required to pump H+ ions and thus provide 
the acidic environment required by lysosomal hydrolases (reviewed in [7]). 
It is becoming clear that the lysosome does not solely function as a recycling centre. There is now 
evidence that lysosomes can undergo secretion, which appears to be important for plasma 
membrane repair and defence from parasites (reviewed in [8]). The lysosome is also gaining 
prominence as a nutrient signalling hub, with the v-ATPase playing an important role in sensing 
amino acid availability. This review will focus on the expanded cellular role of the lysosome, 
describing both its well-known role in autophagy as well as new research linking it to nutrient 
signalling more broadly (Figure 1). 
2. The role of the lysosome in autophagy 
The autophagic process begins with the formation of an isolation membrane (phagophore). This 
membrane expands through the coordinated action of autophagy related (ATG) proteins to form an 
autophagosome and engulf the cytoplasmic cargo requiring degradation (reviewed in [9]). 
The Unc51 like kinase, ULK1 (known in yeast as Atg1), forms part of a complex which is key to early 
autophagy signalling (recently reviewed in [10]). The ULK1 complex becomes active under starved 
conditions and coordinates with parallel signals from the Beclin1 complex to initiate autophagosome 
formation. Following the generation of phosphatidylinositol-3-phosphate (PtdIns(3)P) via ULK1 and 
Beclin1 signalling, further ATG proteins are recruited to the nascent autophagosome.  Microtubule-
associated protein 1A/1B-light chain 3 (LC3), a member of the ATG8 family of ubiquitin-like proteins, 
becomes lipidated, allowing LC3 to associate with the autophagosomal membrane and drive 
autophagosomal maturation [11]. The expanded membrane loses association with ATG proteins 
prior to closure around its cargo, but retains LC3 on the inner surface (reviewed in [12]). 
Once sequestered, the cargo within the autophagosome is degraded through autophagosome-
lysosome fusion. The exact mechanism which ensures timely fusion is not fully eludicated, but it was 
hypothesised that soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor 
(SNARE) proteins were likely to be involved due to their known role in vesicle fusion [13]. Two 
studies then showed that the SNARE protein, syntaxin 17 (STX17), was important for 
autophagosome-lysosome fusion [14,15]. The proposed mechanism is that STX17 becomes tethered 
onto the outer surface of an autophagosome, where it recruits synaptosomal-associated protein 29 
(SNAP29) [15]. ATG14 associates with STX17 and SNAP29 to stabilise this complex on 
autophagosomes, priming it for interaction with vesicle associated membrane protein (VAMP) 8 
[16]. VAMP8 is localised on endosomes and lysosomes, thus the formation of a STX17-SNAP29-
VAMP8 complex allows autophagosome-lysosome fusion [15]. Furthermore, lysosomal-associated 
membrane protein (LAMP) 2, a commonly used marker of lysosomes, has recently been shown to be 
essential for STX17 expression on autophagosomes and the absence of LAMP2 also alters the 
recruitment of accessory proteins required for tethering and fusion [17]. 
Interestingly, autophagosome-lysosome fusion has been revealed as important for activating 
lysosomal function, as chemical inhibitors of the fusion process lead to a reduction in cathepsin B 
activity (as a read-out of lysosomal function) under starved conditions [18]. Additionally, cathepsin B 
activity fails to increase under starvation in cells with constitutively active mammalian target of 
rapamycin complex 1 (mTORC1) signalling [18]. mTORC1 signalling (covered in detail in Section 3 
below) drives anabolic activities within the cell, and so functions in contrast to catabolic processes 
such as autophagy. There are several layers of cross-talk between these pathways in which the 
lysosome plays a role, which will be covered in Section 4. 
3.1 mTORC1 regulates protein homeostasis and cell growth 
The mammalian target of rapamycin complex 1 (mTORC1) plays a fundamental role in the 
integration of metabolic, energy, hormonal and nutritional signals to promote biosynthetic pathways 
and suppress the catabolic process of autophagy. mTORC1 is a major regulator of protein 
homeostasis and thus cell growth. It exerts its effects by phosphorylating and controlling the activity 
of key ribosomal proteins such as ribosomal protein S6 (rpS6) and inhibiting the translation 
repressor, eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1). In addition, mTORC1 
controls lipogenesis, glycolysis and mitochondrial biogenesis [19]. mTORC1 is a multi-protein 
complex consisting of mTOR protein kinase, regulatory-associated protein of mTOR (Raptor) (a 
scaffold protein involved in substrate recruitment), mammalian lethal with SEC13 protein 8 
(mLST8)/GβL ;ǁhiĐh staďilises ŵTO‘-Raptor interaction) [20] and the negative regulators proline-
rich Akt substrate of 40 kDa (PRAS40) [21] and DEP Domain Containing MTOR-Interacting Protein 
(DEPTOR) [22]. The Đore kiŶase proteiŶ ŵTO‘ ;as ǁell as ŵLSTϴ/GβL aŶd DEPTO‘Ϳ also eǆists aloŶg 
with rapamycin insensitive companion of mTOR (Rictor) and Sin1 as part of a second complex called 
mTORC2 [23]. The function and regulation of this complex is less well understood but has been 
demonstrated to influence the actin cytoskeleton. ŵTO‘CϮ͛s activity is under the influence of 
growth factors and it can phosphorylate Akt [23].  
 
The signals controlling mTORC1 originate from various sources in the cell including the plasma 
membrane (growth factors, hormones and cytokines via receptor tyrosine kinases and G-protein 
coupled receptors), cytoplasm (energy status via AMP-activated protein kinase (AMPK)), 
mitochondria (glutaminolysis, reactive oxygen species and energy status) and the lysosome 
(following degradation and liberation of nutrients). Well described phosphorylation signalling 
cascades, including phosphoinositide 3-kinase (PI3K)/Akt and Ras/extracellular signal–regulated 
kinase (ERK) can transduce these signals to mTORC1. In addition and downstream of these events, it 
is becoming increasingly clear that mTORC1 is further controlled by the differential localisation of a 
range of proteins and organelles, including itself, in response to mitogenic signals. Indeed the cell 
biology of mTORC1 signalling is expanding rapidly and at the very centre of this is the lysosome.  
 
3.2 mTORC1 at the lysosome 
The central role of the lysosome in regulating mTORC1 activity emerged from the identification that 
ŵTO‘Cϭ͛s localisation to Rab7-positive vesicles is required for its activation [24]. Due to the lack of 
highly specific markers, the distinction between, and the relative importance of, the late endosome 
versus the lysosome for mTORC1 activity is currently not clear. However, as the literature has 
primarily focussed on the lysosome as the site of mTORC1 activation, for simplicity we will refer to 
the site of mTORC1 activation as the lysosome for the remainder of the review. mTORC1 localisation 
to lysosomes is dependent on a group of small GTPases called Rag GTPases and a pentameric 
complex called Ragulator (made up of late endosomal/lysosomal adaptor, MAPK and MTOR 
activator (LAMTOR) 1-5) [24–26]. Mammalian Rag GTPases are atypical members of the Ras 
superfamily of small GTPases and function via cycling between GTP and GDP states to control their 
function. They are larger in size (30-50kDa vs 20-25kDa) and lack post-translational prenylation 
modifications required for membrane localisation that are characteristic of typical small GTPases. 
Instead, they are anchored to the lysosomal membrane via the resident Ragulator complex that 
further acts as a guanine nucleotide exchange factor (GEF) for RagA/B [26,27] 
The ‘ag GTPases forŵ a heterodiŵer ;A or B ǁith C or DͿ ǁhere the ͚aĐtiǀe͛ ĐoŶforŵatioŶ ĐoŶsists of 
RagA/B·GTP with RagC/D·GDP which can bind to Raptor and sequester mTORC1 to the lysosomal 
membrane [24–26]. Activation of Rag GTPases and mTORC1 localisation to the lysosome is regulated 
predominantly by amino acid sufficiency [24,25] but also glucose availability [28]. Indeed, 
overexpression of GTP-locked RagA/B renders mTORC1 constitutively active and insensitive to 
removal of amino acids [24,25]. The nucleotide status of Rag GTPases is regulated by a range of GEF 
and GTPase activating proteins (GAPs), with the most notable GEF being the Ragulator [26,27] and 
with GAPs including the GAP activity toward Rags (GATOR) 1 complex (towards RagA/B) [29], the 
tumour suppressor folliculin (FLCN) in complex with FLCN interacting protein (FNIP) 1/2 (towards 
RagC/D) [30] and leucyl tRNA synthetase (towards RagD) [31,32]. 
The recruitment of mTORC1 to the lysosomal membrane is generally considered to bring it into close 
proximity to its master regulator, Ras homolog enriched in brain (Rheb) which resides on the 
lysosome, as well as a number of other endomembranes. Although the exact mechanism of how 
Rheb activates mTOR kinase activity is unknown, the direct interaction between the two is sufficient 
in vitro and in vivo to promote the phosphorylation of mTORC1 substrates [33,34]. The most 
proximal regulator of Rheb is tuberous sclerosis complex (TSC) which consists of TSC1, TSC2 and 
TBC1D7, where TSC2 has GAP activity towards Rheb and enhances the intrinsic hydrolysis of GTP to 
GDP, thus inactivating Rheb and inhibiting mTORC1 [35–39]. TSC is a signalling node that integrates 
inputs from a range of pathways including Ras/ERK, AMPK and PI3K/Akt pathways and is heavily 
regulated by phosphorylation events [36,40,41]. Thus by providing a platform for both Rags and 
Rheb small G proteins, the lysosome creates a signalling hub that tightly controls mTORC1 activity.  
3.3.1 Sensing of amino acids: inside or out? 
Increasing evidence suggests that amino acids can signal to mTORC1 both from the cytoplasm and 
from within the lumen of the lysosome. The first evidence that amino acid sensing may propagate 
from within lysosomes came from the identification that the v-ATPase forms a signalling complex 
with the Ragulator-Rag GTPase.  The mechanism via which the v-ATPase may signal amino acid 
sufficiency is currently not understood; in particular the role of ATPase activity for mTORC1 
activation is not clear. While pharmacological inhibition of ATP hydrolysis activity can inhibit 
mTORC1 [42], others have demonstrated that amino acid starvation may increase ATPase activity 
[43]. Specifically, amino acid deprivation enhances the interaction between Rag GTPases, Ragulator 
and v-ATPase which may be a result of conformational changes [42] and potentially increased v-
ATPase assembly [43]. Furthermore, others have demonstrated that intraluminal pH of the lysosome 
is important to support mTORC1 activity [44]. It is unclear at present whether amino acid sensing via 
the lysosomal lumen involves the direct trafficking of amino acids from the cytoplasm into the 
lysosome or whether the amino acids sensed here are liberated via the degradative nature of the 
lysosome. For example, supplementation of methyl esters [45] or radio-labelled amino acids shows 
they rapidly accumulate in the lysosome [42], while over-expression of the proton-assisted amino 
acid transporter, PAT1, inhibits mTORC1, presumably by leaching amino acids from the lysosomal 
lumen [42]. However, other studies in cells and in vivo in Drosophila, show PAT1 actually supports 
amino acid-dependent mTORC1 activation [46,47] indicating a careful balance in amino acid 
distribution or transport is required for proper mTORC1 activity.  
3.3.2 Sensing of specific amino acids 
Leucine, arginine and glutamine have been widely shown to be the main amino acids contributing to 
mTORC1 activation [26,31,48–51]. A number of mechanisms via which these amino acids can 
influence mTORC1 have now been elucidated, demonstrating the complex control of amino acid 
sensing (Figure 2).  
Glutamine contributes to mTORC1 activation via the process of glutaminolysis which produces 
alpha-ketoglutarate ;α-KG) and is supported by leucine availability as a co-factor for glutamate 
dehydrogenase (GDH) that participates in deamination of glutamine [50]. Interestingly, cell 
perŵeaďle α-KG is sufficient to activate mTORC1 [50] and involves prolyl hydroxylases via a currently 
unknown mechanism [52]. Another mechanism of glutamine sensing has been identified, 
interestingly, in Rag knock-out cells via a mechanism dependent on the v-ATPase and involving the 
Golgi-localised GTPase Arf1 [51]. 
Recently, cytoplasmic sensors of leucine and arginine have been identified to work via very similar 
mechanisms. Sestrin (SESN) 2 has long been known to influence cellular growth and metabolism. 
Recent work has revealed that SESN2 can bind leucine and this is required for leucine-dependent 
mTORC1 activation [53–56]. (Further crosstalk mechanisms between the sestrin proteins, mTORC1 
and AMPK are detailed in Section 5.3). Via a similar mechanism, arginine has recently been shown to 
bind to a protein called CASTOR1.  This interaction prevents CASTOR1-GATOR2 interaction, freeing 
GATOR2 to inactivate GATOR1, leading to increased Rag-dependent mTORC1 signalling [57]. 
In addition to sensing via CASTOR1/2 in the cytoplasm and SLC38A9 [58] (see below) via the 
lysosomal lumen, arginine sensing has also been attributed to controlling the interaction of TSC2 
with Rheb at the lysosome [49]. TSC2 recruitment to lysosomes has been linked to various mitogenic 
signals, including growth factors, amino acids (most notably arginine), intracellular pH, osmotic 
stress and mechanical stimulation [49,59–63]. Growth factor and amino acid regulation of TSC2 
localisation occurs via a mechanism that involves Rheb [49,59], although Rag GTPases have also 
been implicated [61]. Interestingly the two reports that focus on Rheb as the main regulator of TSC2 
on lysosomes show that TSC interacts most strongly with Rheb in the absence of growth factors and 
amino acids (arginine) [49], specifically in its GDP-bound state [60] and prevents the interaction of 
Rheb with mTORC1. This is intriguing as classically, most GAP-substrate interactions are transient 
and the GAP quickly dissociates from its substrate upon GTP hydrolysis. This raises the very 
interesting possibility that TSC2 may have additional regulatory roles to that of a GAP. We noted for 
example that overexpression of GAP-deficient mutants of TSC2 can still inhibit Rheb-dependent 
mTORC1 activity and conversely wild-type TSC2 is able to inhibit constitutively active Rheb-
dependent mTORC1 [49]. It remains to be clarified whether perhaps TSC2 can function as a guanine 
nucleotide dissociation inhibitor (GDI) as well as GAP towards Rheb. This is a real possibility as no 
GEF has been identified to activate Rheb but it is generally considered to be highly loaded with GTP.  
3.3.3 Amino acid transporters 
If amino acids are transported directly into the lysosome, it is currently not clear which transporters 
may be involved. It is equally not clear whether specific, individual amino acids are sensed within the 
lysosome or overall amino acid concentration. At present, the only transporter that has been 
implicated in sensing of a specific amino acid from within the lysosome is SLC38A9 which 
participates in sensing arginine following starvation and re-feeding. SLC38A9 has been placed as part 
of the larger sensing platform on lysosomes, by interacting with Ragulator-Rag complex [58,64,65]. 
Interestingly, knock-down of SLC38A9 prevented starvation-induced re-localisation of mTOR to the 
cytoplasm [65] however the mechanism of this retention is unknown.  
The amino acid transporters, SLC7A5 and SLC3A2 (also known as LAT1 and 4F2hc, respectively) can 
be recruited to the lysosomal membrane via a protein called LAPTM4b which helps load the 
lysosome with leucine and activate mTORC1 [66]. These same transporters are important at the 
plasma membrane in controlling uptake of amino acids. Similarly, SLC1A5 transports glutamine into 
the cell, effectively loading the cell with glutamine which can then be used by SLC7A5/SLC3A2 to 
exchange with leucine [67].  
As mentioned above, the proton-assisted transporter, PAT1 has been implicated in controlling amino 
acid-dependent mTORC1 activity and it does this through an interaction with Rag GTPases on 
lysosomal membranes [46,47]. Interestingly, PAT1 transports amino acids including glycine, proline 
and alanine which are not potent mTORC1 activators so it not necessarily clear exactly how PAT1 
may influence mTORC1. More recently, the localisation of PAT1 to the lysosome has been shown to 
be negatively regulated by FLCN levels. Overexpressed FLCN leads to decreased PAT1 localisation to 
the lǇsosoŵe, thus ͚trappiŶg͛ iŶtra-lysosomal amino acids such as leucine and supporting mTORC1 
activity even in amino acid limiting conditions [68]. This is an interesting concept as FLCN is normally 
recruited to lysosomes during amino acid deprivation however perhaps at endogenous levels, FLCN 
concentrations are not sufficient to affect PAT1 and intracellular amino acid levels, thus mTORC1 is 
switched off [69]. Another member of the PAT family, PAT4, localises to the Golgi where it can 
interact with a complex including mTORC1 and the small GTPase, Rab1 to control serine and 
glutamine-dependent activation of mTORC1 [70] possibly by promoting the Rheb-mTORC1 
interaction [71].  
Future perspectives are likely to identify additional amino acid transporters both on the lysosome 
and plasma membrane that contribute to controlling intracellular concentrations of amino acids and 
subsequently mTORC1. One interesting avenue for this research is the idea that amino acid 
transporters can further act as transceptors, functioning via sensing and signalling amino acid 
availability rather than their transport. For example, the non-hydrolysable amino acid substrate, Me-
AIB can activate mTORC1 in cells expressing SLC38A2/SNAT2 [72]. This may also help to explain 
discrepancies including why SLC38A9 specifically senses arginine [58] when it has a higher transport 
affinity for other amino acids, such as glutamine [64] and why PAT1 transports amino acids that are 
not potent mTORC1 activators. It is likely that in addition to specific amino acids, a basal 
concentration of other amino acids is also required to activate mTORC1 [47]. Indeed we have seen 
previously that while leucine, arginine and glutamine together can minimally activate mTORC1, a full 
complement of the other amino acids is required to induce the maximal amino acid-dependent 
mTORC1 signal [49].   
4. Cross-talk between autophagy and mTORC1 
Autophagy is tightly regulated in an inverse manner to anabolic processes mediated by mTORC1 
activity. This regulation is maintained through several points of cross-talk between the two 
pathways. Direct cross-talk occurs through phosphorylation events mediated by the key kinase 
complexes, ULK1 and mTORC1. The ULK1 complex can phosphorylate Raptor within mTORC1 to 
inhibit mTORC1 activity when autophagy is active [73,74]. Conversely, mTORC1 can phosphorylate 
several components within the ULK1 complex in order to downregulate autophagy when nutrients 
are plentiful [75–77]. Additionally, mTORC1 has been shown to regulate the regeneration of 
lysosomes following activation of autophagy. Although mTORC1 is downregulated during the initial 
stages of autophagy, it becomes reactivated several hours later, with the reactivation dependent on 
the release of intracellular nutrients during the autophagic process [5]. This increased mTORC1 
activity inhibits further autophagy and permits the generation of proto-lysosomal tubules which 
extend from autolysosomes before maturing into functional lysosomes [5]. Lysosomal regeneration 
is dependent on phosphorylation of UV irradiation resistance-associated gene (UVRAG) by mTORC1. 
This phosphorylation of UVRAG enhances VPS34 lipid kinase activity, which appears to be critical for 
tubule scission [4]. These feedback mechanisms between mTORC1 and autophagy prevent excessive 
autophagy and keep anabolic and catabolic processes in check. 
Interestingly, feedback from the lysosome itself to mTORC1 signalling has also been documented. In 
addition to the generation of amino acids during autophagy which permit the reactivation of 
mTORC1 as described above [5], it is observed that in chondrocytes, pharmacological inhibition of 
lysosomal function activates mTORC1 signalling independently of autophagy [78]. Similarly, this 
cross-talk operates in reverse, where inappropriate mTORC1 activity prevents lysosomal activation 
under starvation [18]. 
Other interesting nodes of crosstalk between mTORC1 and autophagy are the adaptor protein p62 
(also known as SQSTM1) and microphthalmia-associated transcription factor (MITF). p62 is an 
important mediator of selective autophagy of ubiquitinated proteins [79]. p62 also interacts with the 
mTORC1 component, Raptor, as well as RagC/D [80], thus providing a signalling nexus for mTORC1 
activation on the lysosome.  These multiple roles of p62 have recently been reviewed elsewhere 
[81]. MITF, a basic helix-loop-helix leucine zipper transcription factor, drives transcription of all the 
subunits of the v-ATPase, thus regulating lysosomal metabolism [82]. A conserved regulatory loop 
was reported, whereby activation of mTORC1 at the lysosome (which requires the v-ATPase) 
functions to negatively regulate MITF activity by sequestering MITF in the cytoplasm. Therefore, 
mTORC1, v-ATPase and MITF provide a feedback mechanism to maintain cellular homeostasis [82]. 
In addition to nutrients and mitogenic signals controlling the localisation of mTORC1 and its 
regulators, they also control the subcellular distribution of lysosomes themselves [83]. In nutrient 
replete conditions, lysosomes are distributed to the cell periphery, while starvation leads to the 
perinuclear clustering of lysosomes. Some of the proteins involved in cellular lysosomal positioning 
have recently come to light. For example, the multisubunit complex, BORC, has been shown to 
associate with the cytosolic face of lysosomes, where it recruits the small GTPase, Arl8, to promote 
peripheral movement of lysosomes [84]. Functioning in reverse to mediate the transport of 
lysosomes towards the perinuclear region upon autophagy induction is the PI(3,5)P2—TRPML1—
ALG-2 pathway [85]. 
This lysosomal localisation directly impacts on mTORC1 activity and genetic manipulation of 
lysosomal localisation to the periphery activates mTORC1 while perinuclear clustering inhibits it [83]. 
It is currently not clear however exactly why or how lysosomal positioning can impact on mTORC1 
activity. Recently it was shown that maintenance of perinuclear lysosomes may be mediated by the 
starvation-induced recruitment of FLCN to the lysosome which recruits RILP and interacts with Golgi 
resident Rab34 to tether lysosomes in this region [86]. Furthermore, it is generally considered that in 
the presence of nutrients, being in close proximity to the cell periphery promotes activation of 
mTORC1 via signalling cascades originating from the membrane, however the mechanisms 
controlling the sequestration of lysosomes in these regions are not known. Amino acid and insulin-
dependent increases in PI(3,5)P2 may recruit mTORC1 via Raptor to the plasma membrane [87]. It 
would be interesting to investigate whether this interaction could also control mTORC1-positive 
lysosome localisation. Intriguingly, mTOR has been reported to suppress the calcium efflux function 
of TRPML1 via phosphorylation [88], revealing an additional level of signalling complexity between 
mTOR and lysosomes. 
A further link between autophagy and mTORC1 signalling is AMPK signalling. This functions to inhibit 
anabolic processes and activate autophagy when cellular energy levels are low, as discussed below. 
5.1. AMPK signalling and energy homeostasis 
AMPK is central to the cellular response to low energy levels. It functions as a heterotrimeric protein, 
consisting of a catalytic  subunit, a  subunit and an adenosyl nucleotide binding  subunit (for 
review, see [89]). This complex is sensitive to changes in the cellular AMP/ATP and ADP/ATP ratios, 
where binding of AMP to the  subunit modulates phosphorylation of Thr172 by the LKB1-STRAD-
MO25 complex [90,91]. Once active, AMPK drives processes which will enhance cellular energy 
stores, such as increasing glucose uptake and promoting autophagy while inhibiting biogenic 
synthesis [89]. 
As it is essential for cells to maintain energy and nutrient homeostasis, it has long been appreciated 
that the mTORC1 and AMPK signalling pathways must be coordinated. Over a decade ago, it was 
shown that AMPK could inhibit mTORC1 signalling though the phosphorylation of TSC2, the tumour 
suppressor which functions upstream of mTORC1 [92]. Subsequently, a second level of regulation 
was uncovered when it was found that AMPK could also directly phosphorylate the mTORC1 
component, Raptor, on Ser722 and Ser792. This permits 14-3-3 binding to Raptor, and inhibition of 
mTORC1 signalling [93]. Treatment with biguanides (such as metformin and phenformin) is closely 
associated with AMPK activation [94], so it was interesting that a later report indicated that mTORC1 
can also be inhibited by biguanides in a TSC2- or AMPK-independent manner. Intriguingly, 
biguanides were found to require the Rag GTPases in order to abolish mTORC1 activation [95]. 
Additionally, AMPK coordinates with the ULK1 complex to regulate autophagy. AMPK 
phosphorylates ULK1 on multiple residues to positively regulate autophagy [96–99], but 
interestingly, under starvation, ULK1 can phosphorylate all three AMPK subunits to downregulate 
AMPK activity [100]. This indicates a finely balanced regulatory signalling network.  
New research to better understand the complex crosstalk between the mTORC1 and AMPK signalling 
pathways and their coordinated control of metabolic homeostasis has revealed that the lysosome 
may function as a crucial hub for integration of signalling in response to both nutrients and energy. 
5.2 AMPK at the lysosome 
AMPK was known to be found in both the nucleus and cytoplasm, with its localisation regulated by 
several factors including environmental stress, cell density and MEK-ERK signalling [101]. Although 
both AMPK and lysosomes are intrinsically linked to autophagy, no direct association had been 
reported. The first indication that AMPK may have a specific late endosomal/lysosomal function was 
when its binding partner, AXIN, was found to interact with LAMTOR1 [102]. Although initially linked 
to Wnt signalling [103], AXIN was later identified as a scaffold protein for AMPK and its upstream 
regulator, LKB1, displaying a weak constitutive interaction with both AMPK and LKB1, which is 
enhanced upon glucose starvation or in the presence of AMP. Through this complex, AXIN mediates 
AMP-triggered AMPK activation by LKB1 [104]. LAMTOR1, a lysosome localising protein [26] 
(previously described in Section 3.2) was then subsequently identified through a yeast two-hybrid 
screen as an AXIN interactor [102]. Starvation was found to enhance AXIN/LKB1-AMPK complex 
binding to LAMTOR1 and the other members of the Ragulator, while loss of LAMTOR1 expression 
inhibited AMPK activation. Interestingly, a significant proportion of cellular AMPK was found 
constitutively localised on the late endosome/lysosome membrane and under starvation, phospho-
AMPK was found exclusively on this membrane, indicating that this membrane surface is where LKB1 
phosphorylates AMPK [102]. It was then investigated how the AXIN/LKB1 complex was recruited to 
the Ragulator on the late endosome/lysosome membrane during starvation. It was shown that the 
energy sensor, v-ATPase, which was already known to regulate the Ragulator in response to glucose 
starvation [28], was also required for the enhanced AXIN/LKB1-LAMTOR interaction under starvation 
[102]. 
The involvement of several mTOR activating factors in AMPK localisation and signalling further 
highlights the intrinsic crosstalk between these two pathways. Therefore, Zhang et al elucidated the 
precise mechanisms whereby the v-ATPase/Ragulator could govern both AXIN/LKB1 and mTORC1 
localisation on the lysosome. Their study showed that AXIN is a key component in this regulatory 
mechanism. Not only does it translocate with LKB1 to the lysosome to activate AMPK and thus turn 
on catabolic processes, but it also is important for turning off anabolic processes through facilitating 
starvation-induced lysosomal dissociation and inhibition of mTORC1. AXIN regulates mTORC1 activity 
through its ability to impair the GEF activity of Ragulator, leading to dissociation of mTORC1 from the 
lysosome and the downregulation of mTORC1 signalling [102]. Interestingly, AXIN was found to 
specifically mediate this effect under energy stress and did not regulate mTORC1 activity under 
amino acid deprivation. This suggests that although several core components of amino acid 
signalling and energy sensing are shared, cells can still exquisitely fine-tune their signalling pathways 
through auxiliary proteins, such as AXIN, to respond appropriately to specific environmental cues. 
The key role of the AXIN-Ragulator-v-ATPase axis in controlling both AMPK and mTORC1 is further 
demonstrated by studies assessing the mechanistic action of metformin (N,N-dimethylbiguanide). 
Metformin is widely used to treat type 2 diabetes due to its ability to decrease cellular energy levels. 
A recent study revealed that both AXIN and LAMTOR1 are required for metformin-mediated AMPK 
activation, with evidence that metformin operates to promote the formation of the v-ATPase-
Ragulator-AXIN/LKB1-AMPK complex, thus activating AMPK [105]. In parallel, metformin treatment 
results in dissociation of mTORC1 from v-ATPase-Ragulator [105]. Two further mechanisms of 
mTORC1 downregulation by metformin have also been proposed. In hepatocytes, low 
concentrations of metformin inhibit hepatic mTORC1 signalling, with this inhibition dependent on 
AMPK and the TSC complex [106]. Additionally, metformin treatment has been shown to prevent 
nucleocytoplasmic shuttling of RagC. This means RagC remains predominantly GTP bound and 
cannot activate mTORC1 [107]. The authors propose that disruption of this RagC-mediated mTORC1 
activation might be a mechanistic link between kinase activity and cellular energy levels [107]. 
These mechanistic studies are not the only new links between AMPK signalling and lysosomes. A 
recent study examining AMPK knockout embryonic stem cells (ESCs) surprisingly revealed that 
lysosomal gene expression was substantially decreased in the absence of AMPK, with TFEB, a 
member of the TFE family of transcription factors, the most consistently reduced lysosomal gene 
[108]. TFEB is known to be regulated at the protein level by energy status; in the presence of 
nutrients, mTORC1 can phosphorylate TFEB to inhibit TFEB activity, but TFEB becomes 
hypophosphorylated and localised to the nucleus when energy levels are low [109]. Cells with AMPK 
knockout did not effectively generate hypophosphorylated TFEB, so TFEB failed to shuttle to the 
nucleus. As a result, these cells exhibited diminished lysosome function [108]. 
5.3 Additional crosstalk mechanisms 
A further crosstalk mechanism between AMPK, mTORC1 and the lysosome occurs via the sestrin 
proteins. SESN1 was originally identified in a condition called heterotaxia [110], and the sestrin 
family was found to play a role in re-establishing cellular antioxidant defences [111]. Subsequently, 
sestrins were found to play a broader role in cellular growth repression through inhibition of 
mTORC1. SESN2 was reported to interact with TSC1, TSC2 and AMPK2. Through these interactions, 
sestrins were shown to stimulate AMPK activity, enhance TSC2 phosphorylation and decrease Rheb-
GTP loading, thus downregulating mTORC1 activity [112]. More recent work has indicated that TSC2 
is not essential for mTORC1 downregulation by sestrins [56,113] and sestrins can downregulate 
mTORC1 independently of AMPK via both the Rags and their upstream regulator, GATOR2 [55,113]. 
Several studies demonstrated that mTORC1 inhibition by sestrins is GATOR- and Rag-dependent 
under both normal cell culture conditions or upon amino acid refeeding and that sestrins inhibit 
mTORC1 activity by preventing localization of mTORC1 to the lysosome [55,56,113]. SESN2 was 
shown to bind to GATOR2 in an amino acid sensitive manner. Specifically, leucine binding to SESN2 
prevents SESN2 from interacting with the GATOR2 complex, thus promoting Rag-dependent 
activation of mTORC1 [53,54]. Furthermore, there is evidence that sestrins can interact directly with 
the Rag GTPases and function as a Rag GDI, thus inhibiting mTORC1 through stabilisation of RagA 
GDP binding [113].  
Clearly, elucidating the role of the sestrin family in mTORC1 regulation is still developing and sestrins 
function at multiple points to regulate the amino acid sensing arm of mTORC1 signalling (Figure 3). 
Further illustrating this, the SESN2-GATOR2 interaction can be disrupted in the absence of amino 
acids by inhibition of the v-ATPase which interacts with the Ragulator on the lysosomal surface [56]. 
Ongoing studies will help reveal the complexities of sestrin-mediated inhibition of mTORC1. 
 6. Summary 
It is vital for cellular health that anabolic and catabolic processes are inversely controlled and tightly 
regulated. To this end, multiple levels of crosstalk occur between them. As highlighted in this review, 
recent publications have revealed that the lysosome forms an important integration point for 
multiple signalling pathways, thus providing a spatial hub for both anabolic and catabolic signalling. 
Further scrutiny of proteins such as the lysosomal v-ATPase which is already known to be important 
for mTORC1 signalling (via the Ragulator) and AMPK signalling (via AXIN), along with the 
identification of new components of mTORC1 and AMPK signalling, will deepen our understanding of 
the exquisite control of cellular metabolism. In turn this may reveal pathways which could be 
targeted in disease states where metabolism is dysregulated. 
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Figure Legends 
Figure 1: Overview of the role of the lysosome 
The lysosome is an integral platform in the control of cellular growth and homeostasis. mTORC1 
integrates intra- and extracellular signals of energy (via AMPK), oxygen, amino acid (via Rag GTPases, 
TSC2 and a variety of other proteins/complexes) and nutrient (via TSC2 complex) availability to 
regulate protein translation, gene transcription, glycolysis, lipogenesis, nucleotide synthesis and 
inhibit the catabolic process of autophagy. Thus mTORC1 and the lysosome manage the balance of 
anabolic vs catabolic cellular processes. The lysosome also functions as the ultimate acceptor of 
material to be degraded via autophagy. 
 
Figure 2: Amino acid sensing by mTORC1 
The presence of free amino acids is essential for mTORC1 activation. Leucine, glutamine and arginine 
are the most potent activators of mTORC1 and a number of different mechanisms have been 
identified via which they are sensed and signal to mTORC1. These include cytoplasmic sensors, 
amino acid transporters and v-ATPase on the lysosomal membrane. All mechanisms work to control 
to the nucleotide status of either Rag GTPases or Rheb, the most proximal regulators of mTORC1. 
 
Figure 3: Crosstalk between mTORC1 and AMPK: Sestrins 
Under amino acid starvation, sestrins have been proposed to inhibit mTORC1 signalling at 3 points 
(1) Interaction with AMPK/TSC1/TSC2 to activate AMPK, block TSC1/2 and reduce Rheb activity 
(although subsequent studies have not found evidence of sestrin/TSC2 interaction (2) Blocking 
GATOR2 function, thereby keeping the Rags inactive (3) Stabilising RagA-GDP to keep the Rags 
inactive. Both (2) and (3) maintain mTORC1 inactive in the cytoplasm. In both panels, dashed lines 
represent pathways which are switched off under the conditions described due to upstream 
inhibitory processes. 
 
 
 
 
  
 
